Primary Care POC Diagnostics Market 2024 - By Size, Share, Forecast And Trends Analysis Report 2033

 

The primary care poc diagnostics global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

 

Primary Care POC Diagnostics Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

 

Market Size - The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $15.32 billion in 2023 to $16.46 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%.  The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, shift towards personalized medicine, growing healthcare expenditure,  rise in supportive regulatory frameworks and expedited approval processes, and growing emphasis on early disease detection and prevention strategies.

 

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.  The growth in the forecast period can be attributed to the emergence of infectious disease outbreaks, expanding applications in non-communicable diseases, increasing adoption in home healthcare settings, growth in precision medicine initiatives, rising healthcare infrastructure investments, increasing disease burden, and growing awareness of the importance of early disease detection. Major trends in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, miniaturization and portability of POC diagnostic devices, integration of smart devices, and usage of multiplexing and panel testing in POC diagnostics.

 

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

 

Scope Of Primary Care POC Diagnostics Market

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

 

Primary Care POC Diagnostics Market Overview

 

Market Drivers -The rise in the prevalence of infectious diseases is expected to propel the growth of the primary care POC diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. These diseases spread from one person to another directly or indirectly through contact with contaminated surfaces, air, water, or vectors such as insects. The prevalence of infectious diseases is due to poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage. Primary care POC diagnostics are integral tools for combating the prevalence of infectious diseases by facilitating early detection, timely treatment, and effective disease control measures in diverse healthcare settings. For instance, in October 2023, according to a report published by the UK Health Security Agency, a UK-based government agency responsible for overseeing and managing public health security, the number of HIV diagnoses in England rose by 22% from 3,118 in 2021 to 3,805 in 2022. Furthermore, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, around 10.6 million cases of tuberculosis (TB)  occurred globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the rise in the prevalence of infectious diseases is driving the primary care POC diagnostics market.

 

Market Trends - Major companies operating in the primary care POC diagnostics market are focusing on technologically advanced solutions, such as portable point-of-care RT-PCR solutions, to maximize their revenue in the market. Portable point-of-care (POC) RT-PCR solutions are compact, mobile devices designed to perform real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratory settings. For instance, in October 2022, Genes2Me Pvt. Ltd., an India-based manufacturer of molecular diagnostic solutions, launched the Rapi-Q Point of Care RT PCR solution for diseases such as HPV and tuberculosis. This solution has an eight-well block design with four fluorescent channels, is claimed to be easy to use, and can provide faster results in less than 45 minutes. The Rapi-Q system is portable and lightweight, making it suitable for hospitals, blood banks, health clinics, research laboratories, and airports. The solution offers high sensitivity, accuracy, and performance in detecting various diseases and is compatible with over 50 lyophilized, room-temperature disease detection kits.

 

The primary care poc diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

 

Get an inside scoop of the primary care poc diagnostics market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

 

Regional Insights - North America was the largest region in the primary care POC diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Key Companies - Major companies operating in the primary care POC diagnostics market are  Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

 

Table of Contents

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario

5. Global Primary Care POC Diagnostics Market Size and Growth

.................................

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking

33. Global Primary Care POC Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market Future Outlook and Potential Analysis

36. Appendix

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model